Page 30 - GPD-2-4
P. 30

Gene & Protein in Disease                                      The roles and mechanisms of ETS1 in diseases



               transcription factor. Gene, 711: 143952.           https://doi.org/10.1016/j.bbrc.2015.04.075
               https://doi.org/10.1016/j.gene.2019.143952      53.  Xu C, Liu S, Fu H, et al., 2010, MicroRNA-193b regulates
                                                                  proliferation,  migration  and  invasion  in  human
            43.  Ito H, Duxbury M, Benoit E, et al., 2004, Prostaglandin E2
               enhances pancreatic cancer invasiveness through an Ets-1-  hepatocellular carcinoma cells. Eur J Cancer, 46(15): 2828–
               dependent induction of matrix metalloproteinase-2. Cancer   2836.
               Res, 64(20): 7439–7446.                            https://doi.org/10.1016/j.ejca.2010.06.127
               https://doi.org/10.1158/0008-5472.CAN-04-1177   54.  Allam MM, Diab KA, Khalil FO, et al., 2022, The association
                                                                  between micro-RNA gene polymorphisms and the
            44.  Gao H, Peng C, Liang B, et al., 2014, beta6 integrin induces the
               expression of metalloproteinase-3 and metalloproteinase-9   development of hepatocellular carcinoma in Egyptian
               in colon cancer cells via ERK-ETS1 pathway. Cancer Lett,   patients. Arch Med Sci, 18(1): 62–70.
               354(2): 427–437.                                   https://doi.org/10.5114/aoms/100600
               https://doi.org/10.1016/j.canlet.2014.08.017    55.  Zheng L, Qi T, Yang D, et al., 2013, microRNA-9 suppresses
                                                                  the proliferation, invasion and metastasis of gastric cancer
            45.  Tsai CL, Jung SM, Chi LM, et al., 2021, Glycogen synthase
               kinase-3  beta (GSK3beta)-mediated phosphorylation of   cells through targeting cyclin D1 and Ets1. PLoS One, 8(1):
               ETS1 promotes progression of ovarian carcinoma.  Aging   e55719.
               (Albany NY), 13(10): 13739–13763.                  https://doi.org/10.1371/journal.pone.0055719
               https://doi.org/10.18632/aging.202966           56.  Zheng L, Pu J, Qi T, et al., 2013, miRNA-145 targets v-ets
                                                                  erythroblastosis virus E26 oncogene homolog 1 to suppress
            46.  Phuchareon J, McCormick F, Eisele DW, et al., 2015, EGFR
               inhibition evokes innate drug resistance in lung cancer   the invasion, metastasis, and angiogenesis of gastric cancer
               cells by preventing Akt activity and thus inactivating Ets-1   cells. Mol Cancer Res, 11(2): 182–193.
               function. Proc Natl Acad Sci U S A, 112(29): E3855–E3863.      https://doi.org/10.1158/1541-7786.MCR-12-0534
               https://doi.org/10.1073/pnas.1510733112         57.  Zhang Y, Yan LX, Wu QN, et al., 2011, miR-125b is methylated
                                                                  and functions as a tumor suppressor by regulating the ETS1
            47.  Seidel JJ, Graves BJ, 2002, An ERK2 docking site in the
               Pointed domain distinguishes a subset of ETS transcription   proto-oncogene in  human  invasive  breast  cancer.  Cancer
               factors. Genes Dev, 16(1): 127–137.                Res, 71(10): 3552–3562.
                                                                  https://doi.org/10.1158/0008-5472.CAN-10-2435
               https://doi.org/10.1101/gad.950902
                                                               58.  Li W, Zang W, Liu P, et al., 2014, MicroRNA-124 inhibits
            48.  Myers E, Hill AD, Kelly G,  et al., 2005, Associations and
               interactions between  Ets-1 and  Ets-2 and  coregulatory   cellular proliferation and invasion by targeting Ets-1 in
               proteins,  SRC-1,  AIB1,  and  NCoR  in  breast cancer.  Clin   breast cancer. Tumour Biol, 35(11): 10897–10904.
               Cancer Res, 11(6): 2111–2122.                      https://doi.org/10.1007/s13277-014-2402-2
               https://doi.org/10.1158/1078-0432.CCR-04-1192   59.  Wang R, Ma Y, Yu D, et al., 2015, miR-377 functions as a
                                                                  tumor suppressor in human clear cell renal cell carcinoma
            49.  Tomar S, Plotnik JP, Haley J, et al., 2018, ETS1 induction by
               the microenvironment promotes ovarian cancer metastasis   by targeting ETS1. Biomed Pharmacother, 70: 64–71.
               through focal adhesion kinase. Cancer Lett, 414: 190–204.      https://doi.org/10.1016/j.biopha.2015.01.012
               https://doi.org/10.1016/j.canlet.2017.11.012    60.  Hua S, Lei L, Deng L,  et al., 2018, miR-139-5p inhibits
                                                                  aerobic glycolysis, cell proliferation, migration, and invasion
            50.  Ning S, Chao HJ, Li S,  et al., 2022, The auto-inhibition
               mechanism of transcription factor Ets-1 induced by   in hepatocellular carcinoma via a reciprocal regulatory
               phosphorylation  on  the  intrinsically  disordered  region.   interaction with ETS1. Oncogene, 37(12): 1624–1636.
               Comput Struct Biotechnol J, 20: 1132–1141.         https://doi.org/10.1038/s41388-017-0057-3
               https://doi.org/10.1016/j.csbj.2022.02.025      61.  Zhai W, Ma J, Zhu R, et al., 2018, MiR-532-5p suppresses
                                                                  renal cancer cell proliferation by disrupting the ETS1-
            51.  Wei  W,  Hu  Z,  Fu  H,  et al.,  2012,  MicroRNA-1  and
               microRNA-499 downregulate the expression of the ets1   mediated positive feedback loop with the KRAS-NAP1L1/P-
               proto-oncogene in HepG2 cells. Oncol Rep, 28(2): 701–706.   ERK axis. Br J Cancer, 119(5): 591–604.
                                                                  https://doi.org/10.1038/s41416-018-0196-5
               https://doi.org/10.3892/or.2012.1850
                                                               62.  Jin L, Huang S, Guan C,  et al., 2020, ETS1-activated
            52.  Ma N, Chen F, Shen SL,  et al., 2015, MicroRNA-129-5p
               inhibits hepatocellular carcinoma cell metastasis and   SNHG10 exerts oncogenic functions in glioma via targeting
               invasion via targeting ETS1. Biochem Biophys Res Commun,   miR-532-3p/FBXL19 axis. Cancer Cell Int, 20(1): 589.
               461(4): 618–623.                                   https://doi.org/10.1186/s12935-020-01649-2


            Volume 2 Issue 4 (2023)                         9                        https://doi.org/10.36922/gpd.2141
   25   26   27   28   29   30   31   32   33   34   35